Neovascularization in intimal hyperplasia is associated with vein graft failure after coronary artery bypass surgery

Vascular Medicine

Volumn 8, Issue 3, 2003, Pages 163-167

  Baklanov, Dmitri V ^a   Peters, Kevin G ^a   Seidel, Amy L ^a   Taylor, Doris A ^a   Annex, Brian H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Endothelial cells; Ischemia

Indexed keywords

AGED; ANALYSIS OF VARIANCE; ANGIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROMA; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; FEMALE; GRAFT FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; MORPHOMETRICS; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; REOPERATION; STATISTICAL SIGNIFICANCE; STENOSIS; VEIN GRAFT;

AGED; CORONARY ARTERY BYPASS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; NEOVASCULARIZATION, PATHOLOGIC; TIME FACTORS; TUNICA INTIMA;

EID: 1242351824     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x03vm488oa     Document Type: Article

References (17)

1. Cox JL, Chiasson DA, Gotlieb AI. Stranger in a strange land: the pathogenesis of safenous graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis 1991; 34: 45-68.
2. Lytle BW. The clinical impact of atherosclerotic saphenous vein to coronary artery bypass grafts. Semin Cardiovasc Surg 1994; 6: 81-86.
3. Campeau L, Enjadlbert M, Lesperance J. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential studies at 2 weeks, 1 year, 5-7 years, and 10-12 years after surgery. Circulation 1983; 68 (Suppl II): II-1-II-7.
4. Kern WH, Dermer GB, Lindesmith GG. The intimal proliferation in aortic-coronary saphenous vein grafts. Am Heart J 1972; 84: 771-77.
5. Mautner SL, Mautner GC, Hunsberg SA, Roberts WC. Comparison of composition of atherosclerotic plaques in native coronary arteries in the same men. Am J Cardiol 1992; 70: 1380-87.
6. Bulkleye BH, Hutchins GM. Accelerated 'atherosclerosis': a morphologic study of 97 saphenous vein coronary artery bypass grafts. Circulation 1977; 55: 163-91.
7. Kahlon R, Shapero J, Gotlieb AI. Angiogenesis in atherosclerosis. Can J Cardiol 1992; 8: 60-64.
8. Ip JH, Fuster V, Badimon L, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: the role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15: 1667-87.
9. Stary HC, Chandler AB, Dinsmore RE et al. A definition of advanced types of atherosclerotic lesions and a histologic classification of atherosclerosis. Circulation 1995; 92: 1355-74.
10. Davies MG, Hagen PO. Pathobiology of intimal hyperplasia. Br J Surg 1994; 81: 1254-69.
11. Tenaglia AN, Peters KG, Sketch MH Jr, Annex BH. Neovascularization in atherectomy specimens from patients with unstable angina. Am Heart J 1998; 135: 10-14.
12. Barger AC, Beeuwkes R, Lainey L, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. N Engl J Med 1984; 310: 175-77.
13. O'Brien ER, Garvin MR, Dev R et al. Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol 1994; 145: 883-94.
14. Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J. Angogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999; 99(13): 1726-32.
15. Celletti FL, Waugh JM, Amabile PG, Brendolan A, Hilfiker PR, Dake MD. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nature Med 2001; 7: 425-29.
16. Ware JA. Too many vessels? Not enough? The wrong kind? The VEGF debate continues. Nature Med 2001; 7:425-29.
17. Moulton KS, Vakili K, Zurakowski D et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003; 100: 4736-41.